●A controlled human infection model could greatly enhance our ability to produce new tuberculosis vaccines. How could that be done safely and still be informative?
●The New England Journal of Medicine publishes many studies that immediately affect medicalpractice and health policy. How does the decision-making process work and how does that affect you as an author?
●This seminar was jointly held by UTOPIA and IJURC.
* The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA)
* IMSUT International Joint Usage/Research Center (IJURC)
Combatting tuberculosis and publishing in medical journals
国際共・共拠点セミナー
開催情報
| 開催日時 | 2024年7月12日（金）16：00～17：30 |
|---|---|
| 開催場所 | 1号館講堂 |
| 演者 | ERIC J. RUBIN, MD, PHD |
| 所属・職名 | Editor-in-Chief, The New England Journal of Medicine, NEJM Group |
| 国名 | アメリカ |
| 演題 | Combatting tuberculosis and publishing in medical journals |
| 使用言語 | 英語 |
| 世話人 | 河岡義裕 |